News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven
July 5, 2017
·
3 min read
Deals
Why Vertex Could Still Be Gilead’s Best Takeover Option
June 30, 2017
·
1 min read
Biotech Bay
Is Gilead On The Verge Of A Powerful Rally?
June 22, 2017
·
1 min read
Deals
Why This Tiny Massachusetts Biotech Could be a New M&A Target for Drug Giants Like Gilead and Celgene
June 16, 2017
·
2 min read
Deals
Gilead, Sanofi Reportedly Bidding on This $10 Billion Massachusetts Biotech
June 13, 2017
·
2 min read
BioMidwest
The Single Best Hep C Drug Stock to Buy in 2017—Hint, It’s Not Gilead
June 9, 2017
·
2 min read
Drug Development
A Look at Gilead’s Possible New Drug Strategy
May 31, 2017
·
3 min read
Biotech Bay
How To Double Your Money On A 6% Up Move In Gilead
May 25, 2017
·
1 min read
Biotech Bay
Why Gilead Stock Lagged Behind Other Biotechs In April
May 10, 2017
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration
December 25, 2025
·
8 min read
Press Releases
Gilead Sciences to Present at Upcoming Investor Conference
December 23, 2025
·
1 min read
Press Releases
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 23, 2025
·
8 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
Press Releases
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 22, 2025
·
5 min read
Press Releases
Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance
December 19, 2025
·
2 min read
Press Releases
Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacapavir for HIV Treatment Meets Primary Endpoint in Phase 3 ARTISTRY-2 Trial
December 16, 2025
·
9 min read
Press Releases
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
December 15, 2025
·
13 min read
Press Releases
Gilead Foundation Awards Over $3 Million to Support People Living With Metastatic Breast Cancer
December 10, 2025
·
4 min read
Press Releases
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
December 9, 2025
·
19 min read
